Find HDV and Determine Its Status in Turkey "SITU(HD)VATION"
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 20,000
- 试验地点
- 2
- 主要终点
- The frequency of HDV in certain regions of Southern Anatolia
研究概览
简要总结
The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.
详细描述
Study Objectives:
The aim of these study to determine the prevalence of HDV infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing HBV, HDV, HCV, and HIV infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.
Primary Objectives:
To reveal the status of HDV infection in Turkey within the framework of the national hepatitis elimination program by providing training to family physicians.
Second Objectives:
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Adults (Age≥18)
- •Being HBsAg positive for at least six months
- •Being a citizen of the Republic of Türkiye
排除标准
- •There are no exclusion criteria in this study.
结局指标
主要结局
The frequency of HDV in certain regions of Southern Anatolia
时间窗: 01.04.2024-30.09.2024
The primary endpoint of this study is to determine the frequency of HDV in certain regions of Southern Anatolia, and the virological and liver fibrosis status of patients with HDV infection.
次要结局
- The rate of HIV and HCV co-infection in HDV positive patients(01.04.2024-30.09.2024)
研究者
Yaşar Bayındır, MD
Chief Physician, Prof. Dr., M.D.
Guven Health Group